Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Entecavir exhibits superior antiviral activity to adefovir in CHB patients

Nov. 17, 2009

Promising preclinical and phase IIa data on S/GSK-1349572 disclosed

Nov. 16, 2009

Phase I/II data show VIR-576 to be safe and effective in HIV

Nov. 16, 2009

BMS-650032 shows potent anti-HCV activity in two phase II trials

Nov. 16, 2009

ITMN-191 monotherapy for HCV infection correlates with high barrier to viral escape

Nov. 16, 2009

AST-120 improves pruritus in patients with chronic liver disease

Nov. 16, 2009

Analyses of phase III data detail activity of fidaxomicin against C. difficile infection

Nov. 16, 2009

HIV infection therapeutic TBR-652 shows good PK and safety profile in healthy subjects

Nov. 13, 2009

INX-189 exhibits anti-HCV activity in vitro and extensive liver delivery in vivo

Nov. 13, 2009

TMC-435 retreatment successful in HCV patients

Nov. 13, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...